The 2012 US Cancer Diagnostics Market

The 2012 US Cancer Diagnostics Market


March 28, 2012
620 Pages - SKU: VPG3815841
License type:
PDF E-mail From Publisher      US $8,700.00
Global Site License Fulfilled by Publisher      US $19,100.00
Countries covered: United States

This report presents a comprehensive analysis of the US cancer diagnostics market, including:

 

  • Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.
  • Ten-year test volume and sales forecasts for 40 cancer diagnostic procedures performed in US hospitals, commercial laboratories, physician offices and cancer clinics.
  • Placements and installed base of automated and semiautomated analyzers used for cancer testing.
  • Current instrumentation technologies and feature comparison of leading analyzers.
  • Sales and market shares of leading suppliers.
  • Emerging diagnostic technologies and their potential market applications.
  • Product development opportunities.
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for suppliers.
Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.



More Oncology/Hematology reports by Venture Planning Group

The US Hematology Market 2014: Instrument and Consumable Sales Forecasts by Market Segment, Key Supplier Shares by Venture Planning Group
The US Hematology Market 2014: Instrument and Consumable Sales Forecasts by Market Segment, Key Supplier Shares This report provides an overview of the US ...
The US Cancer Diagnostic Testing Market 2014: Sales Forecasts By Market Segment and Supplier Shares by Test by Venture Planning Group
The US Cancer Diagnostic Testing Market 2014: Sales Forecasts By Market Segment and Supplier Shares by Test This report provides an overview of the ...
US Hospital Cancer Diagnostics Market 2014 by Venture Planning Group
US Hospital Cancer Diagnostics Market 2014This new report from Venture Planning Group contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital ...
Japanese Hospital Cancer Diagnostics Market 2014 by Venture Planning Group
Japanese Hospital Cancer Diagnostics Market 2014This new report from Venture Planning Group contains 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese ...
See all reports like this >>

More United States Oncology/Hematology reports

United States and Japan – Proton Therapy Market, Patients & Forecast by Renub Research
United States and Japan – Proton Therapy Market, Patients & Forecast Proton therapy has become a subject of considerable interest in the radiation oncology community ...
US Personalized Cancer Genome Sequencing Market Outlook 2018 by RNCOS
US Personalized Cancer Genome Sequencing Market Outlook 2018 The whole genome sequencing technology, over the past decade, has developed at an unprecedented rate. There has ...
The US Hematology Market 2014: Instrument and Consumable Sales Forecasts by Market Segment, Key Supplier Shares by Venture Planning Group
The US Hematology Market 2014: Instrument and Consumable Sales Forecasts by Market Segment, Key Supplier Shares This report provides an overview of the US ...
The US Cancer Diagnostic Testing Market 2014: Sales Forecasts By Market Segment and Supplier Shares by Test by Venture Planning Group
The US Cancer Diagnostic Testing Market 2014: Sales Forecasts By Market Segment and Supplier Shares by Test This report provides an overview of the ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United StatesThis econometric study covers the latent demand outlook for collagen and (hyaluronic ...
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
The 2013-2018 Outlook for Indian Breads in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for Indian breads across the states and cities of the United States. Latent demand (in millions of ...
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
See all reports like this >>